Drug intelligence / Profile preview

nicotine + silver salt

Development stage
Unknown
Lead developer
R.J. Reynolds Tobacco Company
Modality
Small Molecules
Administration
Oral, Buccal, Transdermal
01

Overview

Nicotine + silver salt is a hypothetical or experimental combination drug composed of **nicotine** (typically used in nicotine replacement therapy for smoking cessation) and a **silver salt** (such as silver acetate). Nicotine acts as a nicotinic acetylcholine receptor agonist, reducing withdrawal symptoms and cravings in individuals attempting to quit smoking. Silver salts, particularly silver acetate, have historically been used as aversive agents in smoking cessation by producing an unpleasant metallic taste when combined with cigarette smoke. The rationale is to combine the aversive conditioning effect of the silver salt with the withdrawal-mitigating effect of nicotine, potentially supporting smoking cessation by two complementary mechanisms. However, there is no evidence of a marketed or commonly used product specifically containing this exact combination, and there is little evidence for the efficacy of silver salts in this context relative to standard nicotine replacement therapy[1][4].

Other names
nicotine plus silver saltnicotine and silver acetate
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)

Beyond the preview

Go deeper on nicotine + silver salt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotine + silver salt.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call